Premier Alternatives

AI Optics

New York, NY · Founded 2020 · Privately Held (backing)

Manufacturer of a medical device designed to prevent blindness and vision loss. AI Optics is based in New York, NY and was founded in 2020. It was valued at $30 million at its seed round in Aug 2025, the last priced event on record. It has raised $15 million across 1 recorded round; the latest was a $14.7 million early-stage round in Aug 2025.

PMV mark · valuation
$30.0M
Oct 2026
Priced at
its seed round
Aug 2025
Total raised
$15.0M
Last round
Early Stage VC
Aug 2025

AI Optics key facts

as of Oct 2026
  • Manufacturer of a medical device designed to prevent blindness and vision loss.
  • AI Optics is valued at approximately $30.0M as of Oct 2026, set at its seed round, Aug 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $15.0M across 1 recorded rounds; the latest was Early Stage VC ($14.7M) in Aug 2025.
  • Notable investors include Gaingels, National Institutes of Health, Keiretsu Forum, AlleyCorp, NextCorps Luminate — 11 tracked in total.
  • AI Optics has filed 1 Form D with the SEC, most recently Aug 2025 ($14.7M sold to 92 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$30.0M

Valued at $30.0M at its seed round, Aug 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of AI Optics with a free account
  • ·The complete investor list: 11 names
  • ·Watch AI Optics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

AI Optics funding rounds

1 rounds
Aug 2025Early Stage VC$14.7MSEC filing▮
Full funding history →

AI Optics valuation

AI Optics was valued at $30 million at its seed round in Aug 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has AI Optics raised?

AI Optics has raised $15 million across 1 recorded round since 2025. The largest was a $14.7 million early-stage round in Aug 2025.

AI Optics has filed 1 Form D with the SEC, most recently in Aug 2025 ($14.7 million sold to 92 investors).

AI Optics investors

11 investors are on record for AI Optics, including Gaingels, National Institutes of Health, Keiretsu Forum and AlleyCorp. The early-stage round in Aug 2025 drew 92 investors.

About AI Optics

Manufacturer of a medical device designed to prevent blindness and vision loss. The company's platform combines advanced imaging and artificial intelligence technologies to bring retinal disease screening to the point of care, increasing access and preventing vision loss and blindness, enabling healthcare providers to take eye scans with precision while patients are experiencing vision loss.

Sector
Healthcare
HQ
New York, NY, United States
Founded
2020
Employees
6
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.